Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseases
作者: Hayley M. VerganiGiulia CalviniGloria ManginiFrancesca MattioliAurora ParodiMartina BurlandoGiorgia BodiniAntonietta Martelli
刊名: Int. Journal of Clinical Pharmacology and Therapeutics, 2020, Vol.58 (4), pp.208-213
来源数据库: Dustri-Verlag Dr. Karl Feistle GmbH & Co. KG
DOI: 10.5414/CP203628
原始语种摘要: Objective: To help identify adverse events (AEs) in new biologic therapies and to spread the culture of pharmaceutical surveillance among patients affected by psoriasis or inflammatory bowel disease (IBD). Materials and methods: This active pharmacovigilance program provided all patients with telephone follow-ups (FU), carried out by a clinical pharmacologist for a total duration of 1 year. Collected AEs were classified according to the MedDRA dictionary. Results: 21 patients with psoriasis and 10 patients with IBD were enrolled. In our sample, the AEs reported were frequent but mild, underlining the crucial role of active pharmacovigilance in detecting minor AEs rarely spontaneously reported by the patients. Conclusion: According to our experience, a multidisciplinary team is recommended...
全文获取路径: Dustri出版社 

  • psoriasis 干癣
  • program 程序
  • inflammatory 激怒的
  • affected 受了影响的
  • pharmacologist 药理学家
  • underlining 加下线
  • spontaneously 自发地
  • recommended 推荐
  • therapeutic 治疗的
  • biologic 生物